Cite
HARVARD Citation
Tsang, Y. et al. (2021). Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy. Radiotherapy and oncology. pp. 184-190. [Online].